Literature DB >> 22305571

Rapid expansion of human hematopoietic stem cells by automated control of inhibitory feedback signaling.

Elizabeth Csaszar1, Daniel C Kirouac, Mei Yu, WeiJia Wang, Wenlian Qiao, Michael P Cooke, Anthony E Boitano, Caryn Ito, Peter W Zandstra.   

Abstract

Clinical hematopoietic transplantation outcomes are strongly correlated with the numbers of cells infused. Anticipated novel therapeutic implementations of hematopoietic stem cells (HSCs) and their derivatives further increase interest in strategies to expand HSCs ex vivo. A fundamental limitation in all HSC-driven culture systems is the rapid generation of differentiating cells and their secreted inhibitory feedback signals. Herein we describe an integrated computational and experimental strategy that enables a tunable reduction in the global levels and impact of paracrine signaling factors in an automated closed-system process by employing a controlled fed-batch media dilution approach. Application of this system to human cord blood cells yielded a rapid (12-day) 11-fold increase of HSCs with self-renewing, multilineage repopulating ability. These results highlight the marked improvements that control of feedback signaling can offer primary stem cell culture and demonstrate a clinically relevant rapid and relatively low culture volume strategy for ex vivo HSC expansion.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22305571     DOI: 10.1016/j.stem.2012.01.003

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN: 1875-9777            Impact factor:   24.633


  97 in total

1.  Connecting secretome to hematopoietic stem cell phenotype shifts in an engineered bone marrow niche.

Authors:  Aidan E Gilchrist; Brendan A C Harley
Journal:  Integr Biol (Camb)       Date:  2020-07-10       Impact factor: 2.192

Review 2.  Concise review: stem cell-based approaches to red blood cell production for transfusion.

Authors:  Siddharth Shah; Xiaosong Huang; Linzhao Cheng
Journal:  Stem Cells Transl Med       Date:  2013-12-20       Impact factor: 6.940

Review 3.  Concise review: microfluidic technology platforms: poised to accelerate development and translation of stem cell-derived therapies.

Authors:  Drew M Titmarsh; Huaying Chen; Nick R Glass; Justin J Cooper-White
Journal:  Stem Cells Transl Med       Date:  2013-12-05       Impact factor: 6.940

Review 4.  Engineering stem cell niches in bioreactors.

Authors:  Meimei Liu; Ning Liu; Ru Zang; Yan Li; Shang-Tian Yang
Journal:  World J Stem Cells       Date:  2013-10-26       Impact factor: 5.326

Review 5.  The pharmacology of regenerative medicine.

Authors:  George J Christ; Justin M Saul; Mark E Furth; Karl-Erik Andersson
Journal:  Pharmacol Rev       Date:  2013-07-01       Impact factor: 25.468

Review 6.  Concise review: ex vivo expansion of cord blood-derived hematopoietic stem and progenitor cells: basic principles, experimental approaches, and impact in regenerative medicine.

Authors:  Patricia Flores-Guzmán; Verónica Fernández-Sánchez; Hector Mayani
Journal:  Stem Cells Transl Med       Date:  2013-10-07       Impact factor: 6.940

7.  GM-CSF and IL-4 Fusion Cytokine Induces B Cell-Dependent Hematopoietic Regeneration.

Authors:  Jiusheng Deng; Yanqiu Li; Andrea Pennati; Shala Yuan; Jian Hui Wu; Edmund K Waller; Jacques Galipeau
Journal:  Mol Ther       Date:  2017-02-01       Impact factor: 11.454

Review 8.  Gene Therapy for the Treatment of Primary Immune Deficiencies.

Authors:  Caroline Y Kuo; Donald B Kohn
Journal:  Curr Allergy Asthma Rep       Date:  2016-05       Impact factor: 4.806

9.  Rapamycin enhances long-term hematopoietic reconstitution of ex vivo expanded mouse hematopoietic stem cells by inhibiting senescence.

Authors:  Yi Luo; Lei Li; Ping Zou; Jie Wang; Lijian Shao; Daohong Zhou; Lingbo Liu
Journal:  Transplantation       Date:  2014-01-15       Impact factor: 4.939

Review 10.  Haematopoietic stem cell self-renewal in vivo and ex vivo.

Authors:  Adam C Wilkinson; Kyomi J Igarashi; Hiromitsu Nakauchi
Journal:  Nat Rev Genet       Date:  2020-05-28       Impact factor: 53.242

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.